Yunfei Wang

发表

NanoRNP Overcomes Tumor Heterogeneity in Cancer Treatment.

Chuanlu Jiang, Yingli An, Linqi Shi, 2019, Nano letters.

Genomic landscapes by multiregion sequencing combined with circulation tumor DNA detection contribute to molecular diagnosis in glioblastomas

Chao Yang, C. Kang, Chuan Fang, 2019, Aging.

Single-cell RNA-seq reveals RAD51AP1 as a potent mediator of EGFRvIII in human glioblastomas

C. Kang, Xing Liu, Chuan Fang, 2019, Aging.

Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway

Chuanlu Jiang, Chao Yang, Sijing Zhang, 2018, Theranostics.

Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein

C. Kang, Yunfei Wang, Junhu Zhou, 2021, Theranostics.

Neuronal STAT3/HIF-1α/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A

C. Kang, Yanli Tan, Yunfei Wang, 2022, Theranostics.

Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma

C. Kang, Yunfei Wang, Junhu Zhou, 2021, Molecular Therapy.

FUNDC1-dependent mitophagy induced by tPA protects neurons against cerebral ischemia-reperfusion injury

Ji Liu, Ying Cai, C. Kang, 2020, Redox biology.

UBE2C induces EMT through Wnt/β-catenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A

C. Kang, Yunfei Wang, Xi Liu, 2017, International journal of oncology.

RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner

Chao Yang, C. Kang, Hua You, 2019, Cell Death & Disease.

EGFR/c-myc axis regulates TGFβ/Hippo/Notch pathway via epigenetic silencing miR-524 in gliomas.

Kai Huang, Chao Yang, C. Kang, 2017, Cancer letters.

Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma

Kai Huang, T. Jiang, Chao Yang, 2019, Advanced science.

LncRNA PRADX-mediated recruitment of PRC2/DDX5 complex suppresses UBXN1 expression and activates NF-κB activity, promoting tumorigenesis

C. Kang, Xing Liu, Chuan Fang, 2021, Theranostics.

Long non-coding RNA HOTAIR mediates the switching of histone H3 lysine 27 acetylation to methylation to promote epithelial-to-mesenchymal transition in gastric cancer

Yunfei Wang, Xi Liu, Qingyu Zhang, 2018, International journal of oncology.

The CRISPR/Cas9 system targeting EGFR exon 17 abrogates NF-κB activation via epigenetic modulation of UBXN1 in EGFRwt/vIII glioma cells.

Kai Huang, Chao Yang, C. Kang, 2017, Cancer letters.

PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma

C. Kang, Xing Liu, Chuan Fang, 2022, Frontiers in Immunology.

HOTAIR upregulates an 18-gene cell cycle-related mRNA network in glioma.

Kai Huang, Chao Yang, C. Kang, 2017, International journal of oncology.

PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma

Chunsheng Kang, Xing Liu, Chuan Fang, 2022, Theranostics.

PTRF/CAVIN1, regulated by SHC1 through the EGFR pathway, is found in urine exosomes as a potential biomarker of ccRCC.

C. Kang, Yanli Tan, Yunfei Wang, 2020, Carcinogenesis.

Long Noncoding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding EZH2

Chuanlu Jiang, Qun Chen, C. Kang, 2017, Clinical Cancer Research.

Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ß1 secretion

Xiulan Zhao, C. Kang, Xuan Zhou, 2018, Molecular Cancer.

Diagnostic Values of miR-21, miR-124, and M-CSF in Patients With Early Cervical Cancer

Yunfei Wang, Yun Chai, Fang Ruan, 2020, Technology in cancer research & treatment.

Targeted design and identification of AC1NOD4Q to block activity of HOTAIR by abrogating the scaffold interaction with EZH2

C. Kang, Yu Ren, Yunfei Wang, 2019, Clinical Epigenetics.

Boosting of the enhanced permeability and retention effect with nanocapsules improves the therapeutic effects of cetuximab

Chao Yang, C. Kang, Xubo Yuan, 2020, Cancer biology & medicine.

A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep

Chao Yang, C. Kang, Yu Ren, 2019, Theranostics.

HOTAIR Up-Regulation Activates NF-κB to Induce Immunoescape in Gliomas

C. Kang, Xing Liu, Yanli Tan, 2021, Frontiers in Immunology.

EGFR/EGFRvIII remodels the cytoskeleton via epigenetic silencing of AJAP1 in glioma cells.

Kai Huang, Chao Yang, C. Kang, 2017, Cancer letters.

Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy

Jin Zhao, C. Kang, Xubo Yuan, 2020, Theranostics.

EGFR‐vIII downregulated H2AZK4/7AC though the PI3K/AKT‐HDAC2 axis to regulate cell cycle progression

Chao Yang, C. Kang, Hongyu Zhao, 2020, Clinical and Translational Medicine.

EGFR-vIII downregulated H2AZK4/7AC though the PI3K/AKT-HDAC2 axis to regulate cell cycle progression

Chao Yang, C. Kang, Hongyu Zhao, 2020, Clinical and Translational Medicine.

PTRF/Cavin1 remodels phospholipid metabolism to promote tumor proliferation and suppress immune responses in glioblastoma by stabilizing cPLA2.

Chao Yang, C. Kang, Chuan Fang, 2020, Neuro-oncology.

Homotrimer cavin1 interacts with caveolin1 to facilitate tumor growth and activate microglia through extracellular vesicles in glioma

Chao Yang, C. Kang, Yanli Tan, 2020, Theranostics.

Early administration of MPC-n(IVIg) selectively accumulates in ischemic areas to protect inflammation-induced brain damage from ischemic stroke

Chunsheng Kang, Xubo Yuan, Yunfei Wang, 2021, Theranostics.

Downregulation of miRNA-146a-5p promotes malignant transformation of mesenchymal stromal/stem cells by glioma stem-like cells

Hongwei Cheng, X. Dai, C. Kang, 2020, Aging.

Expert opinion on translational research for advanced glioblastoma treatment

Chunsheng Kang, Yunfei Wang, Junhu Zhou, 2023, Cancer biology & medicine.

Identification of long noncoding RNA HERC2P2 as a tumor suppressor in glioma.

Chao Yang, C. Kang, Hua You, 2019, Carcinogenesis.

Targeted design and identification of AC1NOD4Q to block activity of HOTAIR by abrogating the scaffold interaction with EZH2

C. Kang, Yu Ren, Yunfei Wang, 2019, Clinical Epigenetics.

Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance

C. Kang, Yunfei Wang, Guang-xiu Wang, 2023, Cancer biology & medicine.

Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ß1 secretion

Mei Mei, Xuan Zhou, Yan Dou, 2018, Molecular Cancer.

CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma

Yunfei Wang, Junhu Zhou, Jixing Zhao, 2024, Theranostics.

EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma.

Yunfei Wang, Jixing Zhao, Xiaoteng Cui, 2024, Cancer letters.

Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma

Chunsheng Kang, Guanzhang Li, Chuan Fang, 2023, Cancer communications.

Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a provides a personalized therapeutic strategy for the treatment of human glioblastoma.

C. Kang, Yanli Tan, Yunfei Wang, 2021, Molecular therapy : the journal of the American Society of Gene Therapy.